CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Overground Walkingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06029920
NCT06029920N/ACompleted
CompareCT.gov

The Effect of Overground Walking on the Increase of Brain-Derived Neurotrophic Factor Levels, IL-6, HS-CRP, Cognitive Function, and Quality of Life in the Elderly

Universitas Padjadjaran·interventional·Posted Sep 8, 2023·Updated Nov 7, 2023

In Brief

A clinical study evaluating Overground Walking for Cognitive Impairment and Aging. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this research is to investigate the impact of overground walking as a part of a rehabilitation program on the increase in Brain-derived neurotrophic factor (BDNF) levels, decrease in IL-6 levels, decrease in hs-CRP levels, improvement in cognitive function, and enhancement of quality of life (QOL) in older people with mild cognitive impairment. These findings are anticipated to contribute to the efforts to elevate BDNF levels, cognitive function, and QOL while reducing IL-6 and hsCRP levels in the elderly with mild cognitive impairment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Impairment, Aging
CountriesIndonesia
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedSep 8, 2023
Enrollment StartSep 5, 2023
Primary CompletionOct 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.8 years ago

Interventions

Overground Walkingother

Walk on a flat surface for a distance of 15 meters, with a duration of 20 minutes, increasing by 5 minutes each week until the target heart rate is achieved during the exercise, for 8 weeks.